Results 31 to 40 of about 1,510 (191)

COMPARATIVE EVALUATION OF TACROLIMUS 0.03% OINTMENT VS OLOPATADINE 0.2% EYE DROPS IN THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS

open access: yesPakistan Armed Forces Medical Journal, 2021
Objective: To compare the efficacy of tacrolimus 0.03% ointment to olopatadine 0.2% eye drops in the treatment of vernal keratoconjunctivitis. Study Design: Prospective cross-sectional study.
Hassan Sajjad Rathore   +5 more
doaj   +1 more source

Therapeutic Efficacy of Topical Olopatadine 0.1% Versus Ketotifen Fumarate in Allergic Conjunctivitis

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To compare the therapeutic efficacy of topical Olopatadine 0.1% versus Ketotifen Fumarate among the patients diagnosed with allergic conjunctivitis at Armed forces institute of ophthalmology. Study Design: Prospective comparative study.
Farooq Ul Abidin   +5 more
doaj   +1 more source

Comparative analysis of epinastine vs olopatadine eye drops in moderate allergic conjunctivitis patients [PDF]

open access: yes, 2016
Background: Allergic conjunctivitis is a perennial ocular allergic disease. It is the inflammatory response of the conjunctiva to allergens such as pollen, animal dander, and other environmental allergens.
Sood, Preet   +3 more
core   +1 more source

Clinical forms of allergic eye manifestations: prospects of therapy

open access: yesРоссийский офтальмологический журнал, 2020
The review presents the main clinical forms of eye allergy. The modern classification of conjunctival allergic diseases (CAD) divides them into several types according to the presence or absence of proliferative changes complicated by atopic dermatitis ...
M. A. Kovalevskaya, L. A. Filina
doaj   +1 more source

A COMPARATIVE STUDY OF OLOPATADINE 0.01% COMBINED FLUOROMETHOLONE 0.1% TREATMENT VERSUS OLOPATADINE 0.01% COMBINED KETOROLAC 0.4% TREATMENT IN ALLERGIC CONJUNCTIVITIS IN SAROJINI DEVI EYE HOSPITAL

open access: yes, 2023
Objective: Comparative study of the efficacy of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% in the treatment of Allergic Conjuctivitis. Methods: This was a randomized control trial done on 80
BEGUM, FAHEEM   +5 more
core   +1 more source

A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis

open access: yesAsian Journal of Medical Sciences
Background: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine ...
Sudipto Chatterjee   +3 more
doaj   +1 more source

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in allergic conjunctivitis

open access: yesJournal of Dr. NTR University of Health Sciences
Aim: To compare the efficacy of topical bepotastine 1.5% and olopatadine 0.1% ophthalmic solutions in relieving ocular signs and symptoms of mild to moderate allergic conjunctivitis.
Sunkara Charitha   +3 more
doaj   +1 more source

Enhancement of basophil apoptosis by olopatadine and theophylline

open access: yesAllergy and Asthma Proceedings, 2008
Regulation of basophil survival is an important aspect in the pathogenesis of allergic inflammation associated with local accumulation of basophils. However, pharmacologic modulation of basophil survival is largely unknown except for the apoptosis-enhancing effect of glucocorticoids.
Ayako, Kawakami   +6 more
openaire   +3 more sources

Evaluation of effectiveness of rupatadine and olopatadine in patients of allergic rhinitis at Indore: a randomized control trial [PDF]

open access: yes, 2017
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect productivity and quality of life. Although individually olopatadine and rupatadine are efficacious in AR, data on the head to head study of these drugs in Indian
Jay Shah   +3 more
core   +1 more source

Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology
Background: Allergic conjunctivitis, causing eye inflammation and redness, requires effective treatment with alcaftadine 0.25% and olopatadine 0.2% eye drops.
Sushmma Kalla   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy